XLVI vs. TMED
XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) and TMED (T. Rowe Price Health Care ETF) are both exchange-traded funds - XLVI is a Derivative Income fund actively managed by State Street, while TMED is a Health & Biotech Equities fund managed by T. Rowe Price. At a correlation of -0.29, they often move in opposite directions. XLVI charges 0.35%/yr vs 0.44%/yr for TMED.
Performance
XLVI vs. TMED - Performance Comparison
Loading charts...
Returns By Period
XLVI
- 1D
- 1.53%
- 1M
- 2.15%
- YTD
- 2.50%
- 6M
- 2.57%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TMED
- 1D
- 0.00%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XLVI vs. TMED - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 3.19% |
TMED T. Rowe Price Health Care ETF | -7.14% |
Correlation
The correlation between XLVI and TMED is -0.29, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 4, 2026 | -0.29 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XLVI vs. TMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for State Street Health Care Select Sector SPDR Premium Income ETF (XLVI) and T. Rowe Price Health Care ETF (TMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Drawdowns
XLVI vs. TMED - Drawdown Comparison
The maximum XLVI drawdown since its inception was -8.14%, which is greater than TMED's maximum drawdown of -7.14%. Use the drawdown chart below to compare losses from any high point for XLVI and TMED.
Loading charts...
Drawdown Indicators
| XLVI | TMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -8.14% | -7.14% | -1.00% |
Current DrawdownCurrent decline from peak | -0.97% | -7.14% | +6.17% |
Average DrawdownAverage peak-to-trough decline | -1.94% | -5.00% | +3.06% |
Volatility
XLVI vs. TMED - Volatility Comparison
Loading charts...
Volatility by Period
| XLVI | TMED | Difference | |
|---|---|---|---|
Volatility (1Y)Calculated over the trailing 1-year period | 11.06% | 66.28% | -55.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 11.06% | 66.28% | -55.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 11.06% | 66.28% | -55.22% |
XLVI vs. TMED - Expense Ratio Comparison
XLVI has a 0.35% expense ratio, which is lower than TMED's 0.44% expense ratio.
Dividends
XLVI vs. TMED - Dividend Comparison
XLVI's dividend yield for the trailing twelve months is around 11.17%, while TMED has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 0.00% | 0.00% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 11.17% | 5.73% |
Frequently Asked Questions
XLVI and TMED have a correlation of -0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XLVI is cheaper with a 0.35% expense ratio, compared with 0.44% for TMED.
XLVI has the higher dividend yield at 11.17%, compared with 0.00% for TMED.
XLVI is categorized as Derivative Income, while TMED is Health & Biotech Equities. They also come from different issuers: State Street and T. Rowe Price. Their fees differ too: 0.35% for XLVI and 0.44% for TMED.
Find the right allocation for XLVI and TMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer